India has unveiled its first indigenous H5N1 bird flu vaccine for chickens, aiming to reduce losses from recurring outbreaks and strengthen preparedness. Mint reports the vaccine is priced at about ₹1–2 per dose, while other outlets describe the launch as a protection measure for poultry.
The vaccine is presented as a domestically developed response to H5N1 outbreaks. Free Press Journal adds details that it targets the H5N1 virus clade 2.3.2.1a and was developed by the Indian Council of Agricultural Research–National High Security Animal Disease Institute in Bhopal. It also frames the launch in the context of past widespread outbreaks, including mass culling of poultry, and notes the ministerial remarks about India’s self-reliance.
Across the coverage, the core facts align: India announces a first-of-its-kind indigenous H5N1 vaccine for chickens, launched in connection with H5N1 outbreaks. Differences are mainly in the level of background provided and whether specific pricing and technical details (clade and developer institute) are mentioned.